Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus

Anand Khedkar; Harold Lebovitz; Alexander Fleming; Alan Cherrington; Vinu Jose; Sandeep N. Athalye; Ashwini Vishweswaramurthy

doi:10.1002/cpdd.730

Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.730 ◽

2019 ◽

Vol 9 (1) ◽

pp. 74-86 ◽

Cited By ~ 3

Author(s):

Anand Khedkar ◽

Harold Lebovitz ◽

Alexander Fleming ◽

Alan Cherrington ◽

Vinu Jose ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Pharmacokinetics And Pharmacodynamics ◽

Meal Composition

Download Full-text

First-in-Human, Single-Ascending Dose and Food Effect Studies to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cetagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Clinical Drug Investigation ◽

10.1007/s40261-021-01088-5 ◽

2021 ◽

Author(s):

Lu Wang ◽

Jinmiao Lu ◽

Sufeng Zhou ◽

Yuqing Zhao ◽

Lijun Xie ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Food Effect ◽

Dipeptidyl Peptidase ◽

Pharmacokinetics And Pharmacodynamics ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Safety, pharmacokinetics and pharmacodynamics of multiple-ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2012.01661.x ◽

2012 ◽

Vol 14 (12) ◽

pp. 1114-1122 ◽

Cited By ~ 8

Author(s):

L. A. Morrow ◽

M. Leonsson-Zachrisson ◽

H. Ericsson ◽

M. Wollbratt ◽

M. Knutsson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

The Novel ◽

Pharmacokinetics And Pharmacodynamics ◽

Glucokinase Activator

Download Full-text

Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus

Diabetes Obesity and Metabolism ◽

10.1111/dom.13887 ◽

2019 ◽

Vol 22 (2) ◽

pp. 191-202 ◽

Cited By ~ 2

Author(s):

Hong Zhang ◽

Xiaoxue Zhu ◽

Xiaojiao Li ◽

Hong Chen ◽

Min Wu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Selective Inhibitor ◽

Pharmacokinetics And Pharmacodynamics

Download Full-text

Review for "Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus"

10.1111/dom.13887/v2/review1 ◽

2019 ◽

Author(s):

Kyu Cho

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Selective Inhibitor ◽

Pharmacokinetics And Pharmacodynamics

Download Full-text

Decision letter for "Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus"

10.1111/dom.13887/v2/decision1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Selective Inhibitor ◽

Pharmacokinetics And Pharmacodynamics

Download Full-text

Review for "Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus"

10.1111/dom.13887/v1/review3 ◽

2019 ◽

Author(s):

Kyu Yong Cho

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Selective Inhibitor ◽

Pharmacokinetics And Pharmacodynamics

Download Full-text

Decision letter for "Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus"

10.1111/dom.13887/v3/decision1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Selective Inhibitor ◽

Pharmacokinetics And Pharmacodynamics

Download Full-text

Safety, Pharmacokinetics, and Pharmacodynamics of Globalagliatin, a Glucokinase Activator, in Chinese Patients with Type 2 Diabetes Mellitus: A Randomized, Phase Ib, 28-day Ascending Dose Study

Clinical Drug Investigation ◽

10.1007/s40261-020-00971-x ◽

2020 ◽

Vol 40 (12) ◽

pp. 1155-1166

Author(s):

Shuai Zheng ◽

Feng Shao ◽

Yu Ding ◽

Zhenzhen Fu ◽

Qi Fu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Chinese Patients ◽

Pharmacokinetics And Pharmacodynamics ◽

Phase Ib ◽

Glucokinase Activator ◽

Dose Study

Download Full-text

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus

The Journal of Clinical Pharmacology ◽

10.1002/jcph.955 ◽

2017 ◽

Vol 57 (11) ◽

pp. 1432-1443 ◽

Cited By ~ 23

Author(s):

V. Sahasrabudhe ◽

S. G. Terra ◽

A. Hickman ◽

D. Saur ◽

H. Shi ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Renal Impairment ◽

Pharmacokinetics And Pharmacodynamics

Download Full-text

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

Diabetes Therapy ◽

10.1007/s13300-013-0030-2 ◽

2013 ◽

Vol 4 (2) ◽

pp. 331-345 ◽

Cited By ~ 66

Author(s):

Tim Heise ◽

Leo Seman ◽

Sreeraj Macha ◽

Peter Jones ◽

Alexandra Marquart ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Pharmacokinetics And Pharmacodynamics

Download Full-text